Request a Demo
Australia maintains a complex and nuanced regulatory framework that classifies products as either cosmetics or therapeutic goods. Products designed for external application or oral use may be categorised under either classification, contingent upon their specific formulation, intended purpose, and functional characteristics. Each regulatory pathway—cosmetics and therapeutic goods—encompasses distinct standards and protocols governing safety, quality, efficacy, labelling, and permissible claims.
For international brands seeking market entry to Australia, determining the appropriate regulatory classification can be markedly complex. The inherent intricacies arise from the potential overlap between cosmetic and therapeutic product definitions, which can create significant ambiguity and challenge strategic market positioning.
To provide clarity in this complex regulatory environment, local expert Rhiona Robertson, General Manager of Healthcare Product Specialists, will explore the critical distinctions between Australian cosmetic and therapeutic regulatory frameworks. This session will offer strategic insights into navigating the Cosmetic-Therapeutic Interface, empowering brands to make informed regulatory decisions and ensure compliant market entry.
Notes:
The webinar livestreaming is freely available to all users. You are welcome to register for and participate in the webinar.
Kindly be aware that the access to the slides, recording, and Q&A collection is limited to ChemLinked premium members only [Upgrade now].
